» Articles » PMID: 36142318

Applications of Metabolomics in Calcium Metabolism Disorders in Humans

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Sep 23
PMID 36142318
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenesis of the disorders of calcium metabolism is not fully understood. This review discusses the studies in which metabolomics was applied in this area. Indeed, metabolomics could play an essential role in discovering biomarkers and elucidating pathological mechanisms. Despite the limited bibliography, the present review highlights the potential of metabolomics in identifying the biomarkers of some of the most common endocrine disorders, such as primary hyperparathyroidism (PHPT), secondary hyperparathyroidism (SHPT), calcium deficiency, osteoporosis and vitamin D supplementation. Metabolites related to above-mentioned diseorders were grouped into specific classes and mapped into metabolic pathways. Furthermore, disturbed metabolic pathways can open up new directions for the in-depth exploration of the basic mechanisms of these diseases at the molecular level.

Citing Articles

Combining untargeted and targeted metabolomic profiling reveals principal differences between osteopenia, Osteoporosis and healthy controls.

Tan B, Cheng Y, Li J, Zheng Y, Xiao C, Guo H Aging Clin Exp Res. 2025; 37(1):28.

PMID: 39833609 PMC: 11746959. DOI: 10.1007/s40520-024-02923-3.


New insight into primary hyperparathyroidism using untargeted metabolomics.

Wielogorska-Partyka M, Godzien J, Podgorska-Golubiewska B, Sieminska J, Mamani-Huanca M, Mocarska K Sci Rep. 2024; 14(1):20987.

PMID: 39251672 PMC: 11385525. DOI: 10.1038/s41598-024-71423-1.


Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3-5 not receiving dialysis.

Gan L, Wang L, Li W, Zhang Y, Xu B Front Endocrinol (Lausanne). 2024; 15:1406690.

PMID: 39027473 PMC: 11254665. DOI: 10.3389/fendo.2024.1406690.


Effects of Menaquinone-7 on the Bone Health of Growing Rats under Calcium Restriction: New Insights from Microbiome-Metabolomics.

Yuan Y, Szeto I, Li N, Yang H, Zhou Y, Liu B Nutrients. 2023; 15(15).

PMID: 37571336 PMC: 10421271. DOI: 10.3390/nu15153398.


Metabolism of parathyroid organoids.

Sekhar K, Codreanu S, Williams O, Rathmell J, Rathmell W, McLean J Front Endocrinol (Lausanne). 2023; 14:1223312.

PMID: 37492197 PMC: 10364603. DOI: 10.3389/fendo.2023.1223312.


References
1.
Dunn W, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N . Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011; 6(7):1060-83. DOI: 10.1038/nprot.2011.335. View

2.
Favero C, Carriazo S, Cuarental L, Fernandez-Prado R, Goma-Garces E, Perez-Gomez M . Phosphate, Microbiota and CKD. Nutrients. 2021; 13(4). PMC: 8070653. DOI: 10.3390/nu13041273. View

3.
Juppner H . Phosphate and FGF-23. Kidney Int Suppl. 2011; (121):S24-7. PMC: 3257051. DOI: 10.1038/ki.2011.27. View

4.
Jones G, Kaufmann M . Diagnostic Aspects of Vitamin D: Clinical Utility of Vitamin D Metabolite Profiling. JBMR Plus. 2021; 5(12):e10581. PMC: 8674775. DOI: 10.1002/jbm4.10581. View

5.
Cetani F, Pardi E, Marcocci C . Parathyroid carcinoma: a clinical and genetic perspective. Minerva Endocrinol. 2017; 43(2):144-155. DOI: 10.23736/S0391-1977.17.02737-7. View